Swami Narala
Impact in
- Geriatrics and Gerontology top 5%
- Sirtuins and Resveratrol in Medicine
Papers in
-
- Wnt/β-catenin signaling in development and cancer 2
- Oncology 3
- Cytokine Signaling Pathways and Interactions 2
- Co-authors
- Rama Khokha (8 shared papers)Marco A. Di Grappa (3 shared papers)Sam D. Molyneux (2 shared papers)Yang Shao (3 shared papers)Alexander G. Beristain (2 shared papers)Juan Carlos Zúñiga‐Pflücker (1 shared paper)Aditya Murthy (1 shared paper)Homayoun Vaziri (1 shared paper)
- Journals
- Journal of Clinical Investigation (2 papers)Molecular Biology of the Cell (1 paper)Ecotoxicology and Environmental Safety (1 paper)Journal of Cell Science (1 paper)Immunity (1 paper)
- Partner nations
- CanadaUnited StatesAustria
In The Last Decade
Swami Narala
9 papers receiving 431 citations
Peers
Comparison fields: 5 of 73
- Geriatrics and Gerontology 55
- Aging 12
- Immunology and Allergy 36
- Oncology 162
- Cancer Research 77
Countries citing papers authored by Swami Narala
This map shows the geographic impact of Swami Narala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Swami Narala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Swami Narala more than expected).
Fields of papers citing papers by Swami Narala
This network shows the impact of papers produced by Swami Narala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Swami Narala. The network helps show where Swami Narala may publish in the future.
Co-authors
The 25 scholars most cited alongside Swami Narala, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 107 | |
| 2 | 2008 | 86 | |
| 3 | 2010 | 80 | |
| 4 | 2012 | 61 | |
| 5 | 2015 | 55 | |
| 6 | 2018 | 26 | |
| 7 | 2017 | 14 | |
| 8 | 2021 | 4 | |
| 9 | 2024 | 1 |
About Swami Narala
Swami Narala is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Genetics and Cancer Research, having authored 9 papers that have together received 434 indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (2 papers), Wnt/β-catenin signaling in development and cancer (2 papers), Sarcoma Diagnosis and Treatment (2 papers), Pediatric Hepatobiliary Diseases and Treatments (1 paper), Contact Dermatitis and Allergies (1 paper), Genetic and Kidney Cyst Diseases (1 paper), Dermatology and Skin Diseases (1 paper) and Acute Myeloid Leukemia Research (1 paper). The work is most often cited by research in Geriatrics and Gerontology (55 citations), Aging (12 citations), Immunology and Allergy (36 citations), Oncology (162 citations) and Cancer Research (77 citations). Swami Narala has collaborated with scholars based in Canada, United States and Austria. Frequent co-authors include Rama Khokha, Marco A. Di Grappa, Sam D. Molyneux, Yang Shao, Alexander G. Beristain, Juan Carlos Zúñiga‐Pflücker, Aditya Murthy, Homayoun Vaziri, Josef Penninger and Matthew J. Coussens. Their work appears in journals such as Journal of Clinical Investigation, Molecular Biology of the Cell, Ecotoxicology and Environmental Safety, Journal of Cell Science and Immunity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.